ExpressionEdits

ExpressionEdits develops a computational platform called the Genetic Syntax Engine that uses AI to optimize protein expression through a process called intronization. The technology integrates small synthetic introns into transgenes to enhance the production of proteins that are difficult to scale using conventional methods. The company targets the gene therapy and therapeutic protein markets, offering both an internal pipeline and external partnerships to improve therapeutic potency and precision.